Precursor and Methodology Profiling Studies
Past New Requirement Updated
- Agency
-
Drug Enforcement Administration
Department of Justice
- Solicitation expected
- Estimated value
- $700,001 to $750,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Forecast number
- FY25-DEA-1524-6
- Points of contact
-
- DEA Small Business Program deasmallbusinessprogram@dea.gov
- Devine, Marie T marie.t.devine@dea.gov (571) 362-5807
Forecast details come from the Justice Department's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Drug Enforcement Administration is forecasting a new requirement for Precursor and Methodology Profiling Studies to address the growing threat of novel psychoactive substances (NPS) being abused across the United States. This research and development initiative aims to obtain, study, and evaluate the precursors and methodologies used in the manufacture of emerging drugs, with findings intended to support potential control actions under the Controlled Substances Act (CSA). The estimated solicitation release date is January 1, 2025, with an anticipated award date of January 1, 2026.
The estimated award value ranges from $700,001 to $750,000 for this professional services contract, classified under NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences). Work will be performed at 2560 King Arthur Blvd #102, Lewisville, TX 75056. Primary points of contact include Marie T. Devine, Contracting Officer at marie.t.devine@dea.gov or (571) 362-5807, and the DEA Small Business Program at deasmallbusinessprogram@dea.gov for inquiries regarding small business participation.
Forecast text
There are numerous novel psychoactive substances (NPS) being abused in the United States and they pose a significant risk to the public safety. To best protect the public from the dangers of these new drugs, the DEA needs to be able to not only obtain and study these emerging substances, but also study and evaluate the precursors and methodologies used to make these substances. The study and evaluation of the precursors and methodologies used to make these substances will enrich what is already known about how these substances are made and/or further support control actions to permanently place the precursors and/or substances under the Controlled Substances Act (CSA). This meets the goal of DEA and the Diversion Control Program.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast